Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis

International Review of Cytology

Volumn 242, Issue , 2004, Pages 1-54

  Okamura, Hitoshi ^a   Katabuchi, Hidetaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Epithelial ovarian cancer; Immortalization; Ovarian surface epithelial cells

Indexed keywords

ACTIVIN; CANCER GROWTH FACTOR; CELL ADHESION MOLECULE; CLOMIFENE; CYTOKINE; EPIDERMAL GROWTH FACTOR; ESTROGEN; GONADORELIN; GONADOTROPIN; GROWTH FACTOR; HORMONE; INHIBIN; PLASMIN; PLASMINOGEN ACTIVATOR; SCATTER FACTOR; SEX HORMONE;

BIOLOGY; CANCER DIAGNOSIS; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENICITY; CELL FUNCTION; CELL IMMORTALIZATION; CELL SURFACE; CYTOARCHITECTURE; CYTOLOGY; EMBRYOLOGY; ENDOMETRIUM CELL; EPITHELIUM CELL; ESTROGEN THERAPY; EXTRACELLULAR MATRIX; FAMILIAL CANCER; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; METAPLASIA; MISMATCH REPAIR; MOLECULAR BIOLOGY; MORPHOLOGY; MUTATION; NONHUMAN; ONCOGENE; OVARIECTOMY; OVARY CANCER; OVARY CELL CULTURE; OVARY CYST; OVULATION; PATHOPHYSIOLOGY; POLLUTION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; REVIEW; RISK FACTOR; SCANNING ELECTRON MICROSCOPY; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 10444248830     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(04)42001-4     Document Type: Article

References (223)

1. Adams A.T., Auersperg N. Transformation of rat cultured ovarian surface epithelial cells by Kirsten murine sarcoma virus. Cancer Res. 41:1981;2063-2072
2. Afzal S., Lalani E.-N., Poulsom R., Stubbs A., Rowlinson G., Sato H., Seiki M., Stamp G.W.H. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts. Hum. Pathol. 29:1998;155-165
3. Ahmed N., Pansino F., Baker M., Rice G., Quinn M. Association between α v β 6 integrin expression, elevated p4244 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. J. Cell Biochem. 84:2002a;675-686
4. 6 integrin - a marker for the malignant potential of epithelial ovarian cancer. J. Histochem. Cytochem. 50:2002b;1371-1379
5. Arnold J.M., Mok S.C., Purdie D., Chenevix-Trench G. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br. J. Cancer. 84:2001;352-359
6. Auersperg N., Maines-Bandiera S.L., Dyck H.G., Kruk P.A. Characterization of cultured human ovarian surface epithelial cells: Phenotypic plasticity and premalignant changes. Lab. Invest. 71:1994;510-518
7. Auersperg N., Siemens C.H., Myrdal S.E. Human ovarian surface epithelium in primary culture. In Vitro. 20:1984;743-755
8. Auersperg N., Pan J., Grove B.D., Peterson T., Fisher J., Maines-Bandiera S., Somasiri A., Roskelley C.D. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc. Natl. Acad. Sci. USA. 96:1999;6249-6254
9. Auersperg N., Wong A.S.T., Choi K.-C., Kang S.K., Leung P.C.K. Ovarian surface epithelium: Biology, endocrinology, and pathology. Endocr. Rev. 22:2001;255-288
10. Auersperg N., Ota T., Mitchell W.E. Early events in ovarian epithelial carcinogenesis: Progress and problems in experimental approaches. Int. J. Gynecol. Cancer. 12:2002;691-703
11. Baker V.V., Borst M.P., Dixon D., Hatch K.D., Shingleton H.M., Miller D. C-myc amplification in ovarian cancer. Gynecol. Oncol. 38:1990;340-342
12. Bell D.A., Scully R.E. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer. 73:1994;1859-1864
13. Berchuck A., Kamel A., Whitaker R., Kerns B., Olt G., Kinney R., Soper J.T., Dodge R., Clarke-Pearson D.L., Marks P., McKenzie S., Yin S., Bast R.C. Jr. Overexpression of HER-2neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:1990;4087-4091
14. Berchuck A., Rodriguez G.C., Kamel A., Dodge R.K., Soper J.T., Clarke-Pearson D.L., Bast R.C. Jr. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am. J. Obstet. Gynecol. 164:1991;669-674
15. Berchuck A., Rodriguez G., Olt G., Whitaker R., Boente M.P., Arrick B.A., Clarke-Pearson D.L., Bast R.C. Jr. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β Am. J. Obstet. Gynecol. 166:1992;676-684
16. Berchuck A., Kohler M.F., Hopkins M.P., Humphrey P.A., Robboy S.J., Rodriguez G.C., Soper J.T., Clarke-Pearson D.L., Bast R.C. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol. Oncol. 52:1994a;232-236
17. Berchuck A., Kohler M.F., Marks J.R., Wiseman R., Boyd J., Bast R.C. Jr. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am. J. Obstet. Gynecol. 170:1994b;246-252
18. Berns E.M.J.J., Klijn J.G.M., Henzen-Logmans S.C., Rodenburg C.J., van der Burg M.E.L., Foekens J.A. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int. J. Cancer. 52:1992;218-224
19. Bosari S., Viale G., Radaelli U., Bossi A.P., Bonoldi E., Coggi G. p53 accumulation in ovarian carcinomas and its prognostic implications. Hum. Pathol. 24:1993;1175-1179
20. Brandenberger A.W., Tee M.K., Jaffe R.B. Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: Down-regulation of ER-β in neoplastic tissues. J. Clin. Endocrinol. Metab. 83:1998;1025-1028
21. Brinton L., Gridley G., Persson I., Baron J., Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am. J. Obstet. Gynecol. 176:1997;572-579
22. Bu S.Z., Yin D.L., Ren X.H., Jiang L.Z., Wu Z.J., Gao Q.R., Pei G. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer. 79:1997;1944-1950
23. Cajander S., Bjersing L. Fine structural demonstration of acid phosphatase in rabbit germinal epithelium prior to induced ovulation. Cell Tissue Res. 164:1975;279-289
24. Cannistra S.A., Abu-Jawdeh G., Niloff J., Strobel T., Swanson L., Andersen J., Ottensmeier C. CD44 variant expression is a common feature of epithelial ovarian cancer: Lack of association with standard prognostic factors. J. Clin. Oncol. 13:1995;1912-1921
25. Capo-Chichi C.D., Smith E.R., Yang D.-H., Roland I.H., Vanderveer L., Cohen C., Hamilton T.C., Godwin A.K., Xu X.-X. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer. 95:2002;1802-1815
26. Capo-Chichi C.D., Roland I.H., Vanderveer L., Bao R., Yamagata T., Hirai H., Cohen C., Hamilton T.C., Godwin A.K., Xu X.-X. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer Res. 63:2003;4967-4977
27. Carreiras F., Denoux Y., Staedel C., Lehmann M., Sichel F., Gauduchon P. Expression and localization of αv integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. Gynecol. Oncol. 62:1996;260-267
28. Chan W.-Y., Cheung K.-K., Schorge J.O., Huang L.W., Welch W.R., Bell D.A., Berkowitz R.S., Mok S.C. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am. J. Pathol. 156:2000;409-417
29. Cheng P., Schmutte C., Cofer K.F., Felix J.C., Yu M., Dubeau L. Alterations in DNA methylation are early, but not initial events in ovarian tumorigenesis. Br. J. Cancer. 75:1997;396-402
30. Chien C.-H., Wang F.-F., Hamilton T.C. Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells. Mol. Cell. Endocrinol. 99:1994;11-19
31. Choi K.-C., Auersperg N., Leung P.C.K. Expression and anti-proliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. J. Clin. Endocrinol. Metab. 86:2001a;5075-5079
32. Choi K.-C., Kang S.K., Tai C.-J., Auersperg N., Leung P.C.K. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology. 142:2001b;2351-2360
33. Choi K.-C., Kang S.K., Tai C.-J., Auersperg N., Leung P.C.K. The regulation of apoptosis by activin and transforming growth factor-β in early neoplastic and tumorigenic ovarian surface epithelium. J. Clin. Endocrinol. Metab. 86:2001c;2125-2135
34. Choi K.-C., Kang S.K., Tai C.-J., Auersperg N. Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells. J. Clin. Endocrinol. Metab. 87:2002;2245-2253
35. Cimoli G., Russo P., Billi G., Mariani G.L., Rovini E., Venturini M. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells. Jpn. J. Cancer Res. 82:1991;1196-1198
36. Cliby W., Ritland S., Hartmann L., Dodson M., Halling K.C., Keeney G., Podratz K.C., Jenkins R.B. Human epithelial ovarian cancer allelotype. Cancer Res. 53:1993;2393-2398
37. Clow O.L., Hurst P.R., Fleming J.S. Changes in the mouse ovarian surface epithelium with age and ovulation number. Mol. Cell. Endocrinol. 191:2002;105-111
38. Colgin D.C., Murdoch W.J. Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: Secretion of urokinase-type plasminogen activator. Anim. Reprod. Sci. 47:1997;197-204
39. Corps A.N., Sowter H.M., Smith S.K. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Int. J. Cancer. 73:1997;151-155
40. Cramer D.W., Liberman R.F., Titus-Ernstoff L., Welch W.R., Greenberg R., Baron J.A., Harlow B.L. Genital talc exposure and risk of ovarian cancer. Int. J. Cancer. 81:1999;351-356
41. Cuatrecasas M., Villanueva A., Matias-Guiu X., Prat J. K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases. Cancer. 79:1997;1581-1586
42. Dabrow M.B., Francesco M.R., McBrearty F.X., Caradonna S. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol. Oncol. 71:1998;29-37
43. Davies B.R., Worsley S.D., Ponder B.A.J. Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology. 32:1998;69-80
44. Deligdisch L., Einstein A.J., Guera D., Gil J. Ovarian dysplasia in epithelial inclusion cysts: A morphometric approach using neural networks. Cancer. 76:1995;1027-1034
45. Deligdisch L., Gil J., Kerner H., Wu H.S., Beck D., Gershoni-Baruch R. Ovarian dysplasia in prophylactic oophorectomy specimens. Cytogenetic and morphometric correlations. Cancer. 86:1999;1544-1550
46. de Nictolis M., Garbisa S., Lucarini G., Goteri G., Masiero L., Ciavattini A., Garzetti G.G., Stetler-Stevenson W.G., Fabris G., Biagini G., Prat J. 72-Kilodalton type IV collagenase, type IV collagen, and Ki67 antigen in serous tumors of the ovary: A clinicopathologic, immunohistochemical, and serological study. Int. J. Gynecol. Pathol. 15:1996;102-109
47. Di Blasio A.M., Cremonesi L., Vigano P., Ferrari M., Gospodarowicz D., Vignali M., Jaffe R.B. Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. Am. J. Obstet. Gynecol. 169:1993;1517-1523
48. Di Renzo M.F., Olivero M., Katsaros D., Crepaldi T., Gaglia P., Zola P., Sismondi P., Comoglio P.M. Overexpression of the MetHGF receptor in ovarian cancer. Int. J. Cancer. 58:1994;658-662
49. Easton D.F., Bishop D.T., Ford D., Crockford G.P. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am. J. Hum. Genet. 52:1993;678-701
50. Easton D.F., Ford D., Bishop D. and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 56:1995;265-271
51. Edmondson R.J., Monaghan J.M., Davies B.R. The human ovarian surface epithelium is an androgen responsive tissue. Br. J. Cancer. 86:2002;879-885
52. Emons G., Pahwa G.S., Brack C., Sturm R., Oberheuser F., Knuppen R. Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata. Eur. J. Cancer Clin. Oncol. 25:1989;215-221
53. Enomoto T., Weghorst C.M., Inoue M., Tanizawa O., Rice J.M. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am. J. Pathol. 139:1991;777-785
54. Esteller M., Silva J.M., Dominguez G., Bonilla F., Matias-Guiu X., Lerma E., Bussaglia E., Prat J., Harkes I.C., Repasky E.A., Gabrielson E., Schutte M., Baylin S.B., Herman J.G. Promorter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92:2000;564-569
55. Evangelou A., Letarte M., Jurisica I., Sultan M., Murphy K.J., Rosen B., Brown T.J. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA12 mutations and ovarian cancer cells. Cancer Res. 63:2003;2416-2424
56. Farrow D.C., Weiss N.S., Lyon J.L., Daling J.R. Association of obesity and ovarian cancer in a case-control study. Am. J. Epidemiol. 129:1989;1300-1304
57. Fathalla M.F. Incessant ovulation - A factor in ovarian neoplasia? Lancet. 2:1971;163
58. Felip E., Del Campo J.M., Rubio D., Vidal M.T., Colomer R., Bermejo B. Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy. Cancer. 75:1995;2147-2152
59. Findlay J.K., Xiao S., Shukovski L., Michel U. Novel peptides in ovarian physiology. Inhibin, activin, and follistatin. Adashi E.Y., Leung P.C.K. "The Ovary" 1993;413-432 Raven Press, New York
60. Franceschi S., La Vecchia C., Booth M., Tzonou A., Negri E., Parazzini F., Trichopoulos D., Beral V. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int. J. Cancer. 49:1991a;57-60
61. Franceschi S., Parazzini F., Negri E., Booth M., La Vecchia C., Beral V., Tzonou A., Trichopoulos D. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int. J. Cancer. 49:1991b;61-65
62. Frank T.S., Manley S.A., Olopade O.I., Cummings S., Garber J.E., Bernhardt B., Antman K., Russo D., Wood M.E., Mullineau L., Isaacs C., Peshkin B., Buys S., Venne V., Rowley P.T., Loader S., Offit K., Robson M., Hampel H., Brener D., Winer E.P., Clark S., Weber B., Strong L.C., Rieger P., McClure M., Ward B.E., Shattuck-Eidens D., Oliphant A., Skolnick M.H., Thomas A. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J. Clin. Oncol. 16:1998;2417-2425
63. Fredrickson T.N. Ovarian tumors of the hen. Environ. Health Perspect. 73:1987;35-51
64. Fujita M., Enomoto T., Yoshino K., Nomura T., Buzard G.S., Inoue M., Okudaira Y. Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int. J. Cancer. 64:1995;361-366
65. Galtier-Dereure F., Capony F., Maudelonde T., Rochefort H. Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kiloDalton protein in the human ovarian cancer cell line BG-1. J. Clin. Endocrinol. Metab. 75:1992;1497-1502
66. Gamallo C., Palacios J., Moreno G., Calvo de Mora J., Suarez A., Armas A. β-Catenin expression pattern in stage I and II ovarian carcinomas. Am. J. Pathol. 155:1999;527-536
67. Gardner W.U. Tumorigenesis in transplanted irradiated and nonirradiated ovaries. J. Natl. Cancer Inst. 26:1961;829-853
68. Goldgar D.E., Easton D.F., Cannon-Albright L.A., Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. 86:1994;1600-1608
69. Graham J., Graham R. Ovarian cancer and asbestos. Environ. Res. 1:1967;115-128
70. Green A., Purdie D., Bain C., Siskind V., Russell P., Quinn M., Ward B. the Survey of Women's Health Study Group. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Int. J. Cancer. 71:1997;948-951
71. Gregoire L., Rabah R., Schmelz E.-M., Munkarah A., Roberts P.C., Lancaster W.D. Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro. Clin. Cancer Res. 7:2001;4280-4287
72. Gupta A., Godwin A.K., Vanderveer L., Lu A., Liu J. Hypomethylation of the Synuclein γ gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res. 63:2003;664-673
73. Harlow B., Cramer D., Bell D., Welch W. Perineal exposure to talc and ovarian cancer risk. Obstet. Gynecol. 80:1992;19-26
74. Hartenbach E.M., Olson T.A., Goswitz J.J., Mohanraj D., Twiggs L.B., Carson L.F., Ramakrishnan S. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett. 121:1997;169-175
75. Hartmann L.C., Podratz K.C., Keeney G.L., Kamel N.A., Edmonson J.H., Grill J.P., Su J.Q., Katzmann J.A., Roche P.C. Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J. Clin. Oncol. 12:1994;64-69
76. Heints A., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Creasman W.T., Ngan H., Sideri M., Pecorelli S. Carcinoma of the ovary. J. Epidemiol. Biostat. 6:2001;105-138
77. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 19:2000;2548-2556
78. Horiuchi A., Itoh K., Shimizu M., Nakai I., Yamazaki T., Kimura K., Suzuki A., Shiozawa I., Ueda N., Konishi I. Toward understanding the natural history of ovarian carcinoma development: A clinicopathological approach. Gynecol. Oncol. 88:2003;309-317
79. Hulboy D.L., Rudolph L.A., Matrisian L.M. Matrix metalloproteinases as mediators of reproductive function. Mol. Hum. Reprod. 3:1997;27-45
80. Huntsman D., Resau J.H., Klineberg E., Auersperg N. Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy. Am. J. Pathol. 155:1999;343-348
81. Ito I., Minegishi T., Fukuda J., Shinozaki H., Auersperg N., Leung P.C.K. Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma. Br. J. Cancer. 82:2000;1415-1420
82. Ivarsson K., Sundfeldt K., Brännström M., Janson P.O. Production of steroids by human ovarian surface epithelial cells in culture: Possible role of progesterone as growth inhibitor. Gynecol. Oncol. 82:2001;116-121
83. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.-Y., Carcangiu M.L., Pinkel D., Yang-Feng T.L., Gray J.W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:1995;6172-6180
84. Iyengar T.D., Ng S.-W., Lau C.C., Welch W.R., Bell D.A., Berkowitz R.S., Mok S.C. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 18:1999;257-262
85. Jindal S.K., Snoey D.M., Lobb D.K., Dorrington J.H. Transforming growth factor α localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol. Oncol. 53:1994;17-23
86. Jindal S.K., Ishii E., Letarte M., Vera S., Teerds K.J., Dorrington J.H. Regulation of transforming growth factor α gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol. Reprod. 52:1995;1027-1037
87. Jones P.B.C., Muse K.N., Wilson E.A., Curry T.E. Jr. Expression of plasminogen activator (PA) and a PA inhibitor in human granulosa cells from preovulatory follicles. J. Clin. Endocrinol. Metab. 67:1988;857-860
88. Kacinski B.M., Carter D., Mittal K., Yee L.D., Scata K.A., Donofrio L., Chambers S.K., Wang K.I., Yang-Feng T., Rohrschneider L.R., Rothwell V.M. Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am. J. Pathol. 137:1990;135-147
89. Kacinski B.M., Mayer A.G., King B.L., Carter D., Chambers S. New protein overexpression in benign, borderline, and malignant ovarian neoplasms. Gynecol. Oncol. 44:1992;245-253
90. Kalli K.R., Falowo O.I., Bale L.K., Zschunke M.A., Roche P.C., Conover C.A. Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signaling. Endocrinology. 143:2002;3259-3267
91. Kang S.K., Choi K.-C., Cheng K.W., Nathwani P.S., Auersperg N., Leung P.C.K. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium. Endocrinology. 141:2000a;72-80
92. Kang S.K., Cheng K.W., Nathwani P.S., Choi K.-C., Leung P.C.K. Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth. Endocrine. 13:2000b;297-304
93. Katabuchi H., Okamura H. Cell biology of human ovarian surface epithelial cells and ovarian carcinogenesis. Med. Electron Microsc. 36:2003;74-86
94. Katabuchi H., Rees B.V., Lambers A.R., Ronnett B.M., Blazes M.S., Leach F.S., Cho K.R., Hedrick L. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res. 55:1995a;5556-5560
95. Katabuchi H., Tashiro H., Fukumatsu Y., Miyazaki K., Ito M., Okamura H. A case of early de novo ovarian cancer detected by cytological screening for cervical cancer. J. Jpn. Soc. Gynecol. Pathol. Colposc. 13:1995b;162-166
96. Katabuchi H., Tashiro H., Cho K.R., Kurman R.J., Ellenson L.H. Micropapillary serous carcinoma of the ovary: An immunohistochemical and mutational analysis of p53. Int. J. Gynecol. Pathol. 17:1998;54-60
97. Kihana T., Tsuda H., Teshima S., Okada S., Matsuura S., Hirohashi S. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Jpn. J. Cancer Res. 83:1992;978-984
98. Kim J.-H., Skates S.J., Ueda T., Wong K.-K., Schorge J.O., Feltmate C.M., Berkowitz R.S., Cramer D.W., Mok S.C. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 287:2002;1671-1679
99. King B.L., Carcanagiu M.-L., Carter D., Kiechle M., Pfisterer J., Pfleiderer A., Kacinski B.M. Microsatellite instability in ovarian neoplasms. Br. J. Cancer. 72:1995;376-382
100. Kohler M.F., Kerns B.M., Humphrey P.A., Marks J.R., Bast R.C. Jr., Berchuck A. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet. Gynecol. 81:1993;643-650
101. Koivunen E., Itkonen O., Halila H., Stenman U.-H. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. Cancer Res. 50:1990;2375-2378
102. Koonings P.P., Campbell K., Mishell D.R. Jr., Grimes D.A. Relative frequency of primary ovarian neoplasms: A 10-year review. Obstet. Gynecol. 74:1989;921-926
103. Kruk P.A., Auersperg N. Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix. Am. J. Obstet. Gynecol. 167:1992;1437-1443
104. Kruk P.A., Maines-Bandiera S.L., Auersperg N. A simplified method to culture human ovarian surface epithelium. Lab. Invest. 63:1990;132-136
105. Kruk P.A., Uitto V.-J., Firth J.D., Dedhar S., Auersperg N. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res. 215:1994;97-108
106. Kupryjanczyk J., Thor A.D., Beauchamp R., Merritt V., Edgerton S.M., Bell D.A., Yandell D.W. P53 gene mutations and protein accumulation in human ovarian cancer. Proc. Natl. Acad. Sci. USA. 90:1993;4961-4965
107. Kurbacher C.M., Jäger W., Kurbacher J.A., Bittl A., Wildt L., Lang N. Influence of human luteinizing hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro. Tumor Biol. 16:1995;374-384
108. Kuroda H., Mandai M., Konishi I., Yura Y., Tsuruta Y., Hamid A.A., Nanbu K., Matushita K., Mori T. Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: Possible role of up-regulation of insulin-like growth factor-1 by hCG. Int. J. Cancer. 76:1998;571-578
109. Kuroda H., Mandai M., Konishi I., Tsuruta Y., Kusakari T., Kariya M., Fujii S. Human ovarian surface epithelial (OSE) cells express LHhCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1. Int. J. Cancer. 92:2001;309-315
110. Kyo S., Kanaya T., Takakura M., Tanaka M., Yamashita A., Inoue H., Inoue M. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int. J. Cancer. 80:1999a;804-809
111. Kyo S., Takakura M., Kanaya T., Zhuo W., Fujimoto K., Nishio Y., Orimo A., Inoue M. Estrogen activates telomerase. Cancer Res. 59:1999b;5917-5921
112. Langdon S.P., Hirst G.L., Miller E.P., Hawkins R.A., Tesdale A.L., Smyth J.F., Miller W.R. The regulation of growth and protein expression by estrogen in vitro: A study of 8 human ovarian carcinoma cell lines. J. Steroid Biochem. Mol. Biol. 50:1994;131-135
113. Lau K.-M., Mok S.C., Ho S.-M. Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc. Natl. Acad. Sci. USA. 96:1999;5722-5727
114. Lauchlan S.C. The secondary müllerian system. Obstet. Gynecol. Surv. 27:1972;133-146
115. La Vecchia C., Decarli A., Negri E., Parazzini F., Gentile A., Cecchetti G., Fasoli M., Franceschi S. Dietary factors and the risk of epithelial ovarian cancer. J. Natl. Cancer Inst. 79:1987;663-669
116. Lessan K., Aguiar D., Oegema T., Siebenson L., Skubitz A.P.N. CD44 and β1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am. J. Pathol. 154:1999;1525-1537
117. Li A.J., Baldwin R.L., Karlan B.Y. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am. J. Obstet. Gynecol. 189:2003;22-27
118. Lin J., Lei Z.M., Lojun S., Rao C.V., Satyaswaroop P.G., Day T.G. Increased expression of luteinizing hormonehuman chorionic gonadotropin receptor gene in human endometrial carcinoma. J. Clin. Endocrinol. Metab. 79:1994;1483-1491
119. Longo D.L., Young R.C. Cosmetic talc and ovarian cancer. Lancet. 2:1979;349-351
120. Lu J.J., Zheng Y., Kang X., Yuan J.-M., Lauchlan S.C., Pike M.C., Zheng W. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Gynecol. Oncol. 79:2000;158-168
121. Lukas J., Groshen S., Saffari B., Niu N., Reles A., Wen W.-H., Felix J., Jones L.A., Hall F.L., Press M.F. WAF1Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am. J. Pathol. 150:1997;167-175
122. Lutz V., Reuning U., Krüger A., Luther T., Pildner von Steinburg S., Graeff H., Schmitt M., Wilhelm O.G., Magdolen V. High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice. Biol. Chem. 382:2001;789-798
123. Maines-Bandiera S.L., Auersperg N. Increased E-cadherin expression in ovarian surface epithelium: An early step in metaplasia and dysplasia? Int. J. Gynecol. Pathol. 16:1997;250-255
124. Maines-Bandiera S.L., Kruk P.A., Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am. J. Obstet. Gynecol. 167:1992;729-735
125. Mandai M., Konishi I., Kuroda H., Fukumoto M., Komatsu T., Yamamoto S., Nanbu K., Rao C.H.V., Mori T. Messenger ribonucleic acid expression of LHhCG receptor gene in human ovarian carcinomas. Eur. J. Cancer. 33:1997;1501-1507
126. Marks J.R., Davidoff A.M., Kerns B.J., Humphrey P.A., Pence J.C., Dodge R.K., Clarke-Pearson D.L., Iglehart J.D., Bast R.C. Jr., Berchuck A. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 51:1991;2979-2984
127. Marth C., Zeimet A.G., Herold M., Brumm C., Windbichler G., Müller-Holzner E., Offner F., Feichtinger H., Zwierzina H., Daxenbichler G. Different effects of interferons, interleukin-1β and tumor necrosis factor-α in normal (OSE) and malignant human ovarian epithelial cells. Int. J. Cancer. 67:1996;826-830
128. McClellan M., Kievit P., Auersperg N., Rodland K. Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells. Exp. Cell Res. 246:1999;471-479
129. McMeekin D.S., Burger R.A., Manetta A., DiSaia P., Berman M.L. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol. Oncol. 59:1995;81-86
130. Mittal K.R., Zeleniuch-Jacquotte A., Cooper J.L., Demopoulos R.I. Contralateral ovary in unilateral ovarian carcinoma: A search for preneoplastic lesions. Int. J. Gynecol. Pathol. 12:1993;59-63
131. Mok S. C.-H., Bell D.A., Knapp R.C., Fishbaugh P.M., Welch W.R., Muto M.G., Berkowitz R.S., Tsao S.-W. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53:1993;1489-1492
132. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 275:2000;38949-38952
133. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:1991;901-908
134. Müller M., Dietel M., Turzynski A., Wiechen K. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells. Int. J. Cancer. 77:1998;567-571
135. Murakami J., Nagai N., Ohama K., Tahara H., Ide T. Telomerase activity in ovarian tumors. Cancer. 80:1997;1085-1092
136. Murdoch J., Van Kirk E.A., Murdoch W.J. Hormonal control of urokinase plasminogen activator secretion by sheep ovarian surface epithelial cells. Biol. Reprod. 61:1999;1487-1491
137. Nakamura M., Katabuchi H., Tohya T., Fukumatsu Y., Matsuura K., Okamura H. Scanning electron microscopic and immunohistochemical studies of pelvic endometriosis. Hum. Reprod. 8:1993;2218-2226
138. Nakamura M., Katabuchi H., Ohba T., Fukumatsu Y., Okamura H. Isolation, growth and characteristics of human ovarian surface epithelium. Virchows Arch. 424:1994;59-67
139. Neyns B., Katesuwanasing D., Vermeij J., Bourgain C., Vandamme B., Amfo K., Lissens W., De Sutter P., Hooghe-Peters E., De Greve J. Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium. Oncogene. 12:1996;1247-1257
140. Nicosia S.V., Johnson J.H., Streibel E.J. Isolation and ultrastructure of rabbit ovarian mesothelium (surface epithelium). Int. J. Gynecol. Pathol. 3:1984;348-360
141. Nishiyama T., Tominaga N., Nakajima K., Hayashi T. Quantitative evaluation of the factors affecting the process of fibroblast-mediated collagen gel contraction by separating the process into three phases. Collagen Rel. Res. 8:1988;259-273
142. Nitta M., Katabuchi H., Ohtake H., Tashiro H., Yamaizumi M., Okamura H. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol. Oncol. 81:2001;10-17
143. Obata K., Morland S.J., Watson R.H., Hitchcock A., Chenevix-Trench G., Thomas E.J., Campbell I.G. Frequent PTENMMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58:1998;2095-2097
144. Ohtake H., Katabuchi H., Matsuura K., Okamura H. A novel in vitro experimental model for ovarian endometriosis: The three-dimensional culture of human ovarian surface epithelial cells in collagen gels. Fertil. Steril. 71:1999a;50-55
145. Ohtake H., Katabuchi H., Tanaka N., Fukumatsu Y., Matsuura K., Okamura H. Human ovarian surface epithelial cells can produce tissue-type plasminogen activator and plasminogen activator inhibitor-1. Jpn. J. Fertil. Steril. 44:1999b;147-152
146. Okamura H., Katabuchi H. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital. J. Anat. Embryol. 106:(Suppl. 2):2001;263-276
147. Okamura H., Takenaka A., Yajima Y., Nishimura T. Ovulatory changes in the wall at the apex of the human Graafian follicle. J. Reprod. Fertil. 58:1980;153-155
148. Okamura H., Fukumoto M., Mori T. Prostaglandin-mediated changes of vasculature and collagen degradationsynthesis in the follicle wall during ovulation. Adv. Prostaglandin Thromboxane Leukot. Res. 15:1985;597-599
149. Okamura H., Katabuchi H., Nagai R. Ultrastructure of human ovulation: Histofunctional parameters. Motta P.M. "Microscopy of Reproduction and Development: A Dynamic Approach" 1997;155-161 Antonio Delfino Editore, Rome
150. Okamura H., Katabuchi H., Kanzaki H. Macrophages in reproductive biology. Lewis C., Burke B. "The Macrophages" 2002;548-576 Oxford University Press, London
151. Okubo T., Mok S.C., Chen S. Regulation of aromatase expression in human ovarian surface epithelial cells. J. Clin. Endocrinol. Metab. 85:2000;4889-4899
152. Ong A., Maines-Bandiera S.L., Roskelley C.D., Auersperg N. An ovarian adenocarcinoma line derived from SV40E-cadherin-transfected normal human ovarian surface epithelium. Int. J. Cancer. 85:2000;430-437
153. Owens O.J., Leake R.E. Epidermal growth factor receptor expression in malignant ovary, benign ovarian tumours and normal ovary: A comparison. Int. J. Oncol. 2:1993;321-324
154. Palacios J., Gamallo C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 58:1998;1344-1347
155. Pall M., Friden B.E., Brännström M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: A
156. Park T.-W., Felix J.C., Wright T.C. Jr. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res. 55:1995;4739-4796
157. Parrott J.A., Skinner M.K. Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer. Biol. Reprod. 62:2000;491-500
158. Parrott J.A., Kim G., Mosher R., Skinner M.K. Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer. Mol. Cell. Endocrinol. 167:2000;77-87
159. Pieretti M., Powell D.E., Gallion H.H., Conway P.S., Case E.A., Turker M.S. Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer. Hum. Pathol. 26:1995;398-401
160. Plaxe S.C., Deligdisch L., Dottino P.R., Cohen C.J. Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecol. Oncol. 38:1990;367-372
161. Reich R., Miskin R., Tsafriri A. Follicular plasminogen activator: Involvement in ovulation. Endocrinology. 116:1985;516-521
162. Resta L., Russo S., Colucci G.A., Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet. Gynecol. 82:1993;181-186
163. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. 90:1998;1774-1786
164. Risch H.A., Howe G.R. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prevent. 4:1995;447-451
165. Rodriguez C., Patel A., Calle E., Jacob E., Thun M. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA. 285:2001;1460-1465
166. Roland I.S., Yang W.-L., Yang D.-H., Daly M.B., Ozols R.F., Hamilton T.C., Lynch H.T., Godwin A.K., Xu X.-X. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer. 98:2003;2607-2623
167. Rossing M., Daling J., Weiss N., Moore D., Self S. Ovarian tumors in a cohort of infertile women. N. Engl. J. Med. 331:1994;771-776
168. Rubin S.C., Finstad C.L., Wong G.Y., Almadrones L., Plante M., Lloyd K.O. Prognostic significance of Her-2neu expression in advanced epithelial ovarian cancer: A multivariate analysis. Am. J. Obstet. Gynecol. 168:1993;162-169
169. Sadler T.W. Urogenital system. Sadler T.W. "Langman's Medical Embryology," 8th ed.:2000;304-344 Lippincott Willilams & Wilkins, Philadelphia
170. Salazar H., Godwin A.K., Daly M.B., Laub P.B., Hogan W.M., Rosenblum N., Boente M.P., Lynch H.T., Hamilton T.C. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J. Natl. Cancer Inst. 88:1996;1810-1820
171. Sato N., Tsunoda H., Nishida M., Morishita Y., Takimoto Y., Kubo T., Noguchi M. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60:2000;7052-7056
172. Sato T., Saito H., Morita R., Koi S., Lee J.H., Nakamura Y. Allelotype of human ovarian cancer. Cancer Res. 51:1991;5118-5122
173. Schally A.V. Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis. Peptides. 20:1999;1247-1262
174. Schildkraut J.M., Thompson W.D. Familial ovarian cancer: A population-based case-control study. Am. J. Epidemiol. 128:1988;456-466
175. Schildkraut J.M., Schwingl P.J., Bastos E., Evanoff A., Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet. Gynecol. 88:1996;554-559
176. Schreiber G., Dubeau L. c-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas. Am. J. Pathol. 137:1990;653-658
177. Scully R.E. Ovarian tumors A review. Am. J. Pathol. 87:1977;686-720
178. Scully R.E., Bell D.A., Abu-Jawdeh G.M. Update on early ovarian cancer and cancer developing in benign ovarian tumors. Mason P., Sharp F., Blackett T., Berek J. "Ovarian Cancer, Biological and Therapeutic Challenges" 1994;139-144 Chapman and Hall, London
179. Sherman M.E., Lee J.S., Burks R.T., Struewing J.P., Kurman R.J., Hartge P. Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis. Int. J. Gynecol. Pathol. 18:1999;151-157
180. Shih Y.-C., Kerr J., Hurst T.G., Khoo S.-K., Ward B.G., Chenevix-Trench G. No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms. Gynecol. Oncol. 69:1998;210-213
181. Singer G., Kurman R.J., Chang H.-W., Cho S.K.R., Shih I.-M. Diverse tumorigenic pathways in ovarian serous carcinoma. Am. J. Pathol. 160:2002;1223-1228
182. Skubitz A.P.N., Bast R.C. Jr., Wayner E.A., Letourneau P.C., Wilke M.S. Expression of α6 and β4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am. J. Pathol. 148:1996;1445-1461
183. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin L.J., Stuart S.G., Udove J., Ullrich A., Press M.F. Studies of the HER-2neu proto-oncogene in human breast and ovarian cancer. Science. 244:1989;707-712
184. Stadel B.V. The etiology and prevention of ovarian cancer. Am. J. Obstet. Gynecol. 123:1975;772-774
185. Strand M., Prolla T.A., Liskay R.M., Petes T.D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature. 365:1993;274-276
186. Stratton J.F., Pharoah P., Smith S.K., Easton D., Ponder B.A. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br. J. Obstet. Gynaecol. 105:1998;493-499
187. Stratton J.F., Buckley C.H., Lowe D., Ponder B.A.J. the United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. J. Natl. Cancer Inst. 91:1999;626-628
188. Sundfeldt K., Piontkewitz Y., Ivarsson K., Nilsson O., Hellberg P., Brännström M., Janson P.-O., Enerbäck S., Hedin L. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer. 74:1997;275-280
189. Syed V., Ho S.-M. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Oncogene. 22:2003;6883-6890
190. Syed V., Ulinski G., Mok S.C., Yiu G.K., Ho S.-M. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res. 61:2001;6768-6776
191. Syed V., Ulinski G., Mok S.C., Ho S.-M. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J. Natl. Cancer Inst. 94:2002;617-629
192. Takahashi H., Behbakht K., McGovern P.E., Chiu H.-C., Couch F.J., Weber B.L., Friedman L.S., King M.-C., Furusato M., LiVolsi V.A., Menzin A.W., Liu P.C., Benjamin I., Morgan M.A., King S.A., Rebane B.A., Cardonick A., Mikuta J.J., Rubin S.C., Boyd J. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55:1995;2998-3002
193. Tanimoto H., Yan Y., Clarke J., Korourian S., Shigemasa K., Parmley T.H., Parham G., O'Brien T.J. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res. 57:1997;2884-2887
194. Tashiro H., Miyazaki K., Okamura H., Iwai A., Fukumoto M. c-myc over-expression in human primary ovarian tumours: Its relevance to tumour progression. Int. J. Cancer. 50:1992;828-833
195. Tashiro H., Fukumoto M., Miyazaki K., Okamura H. Biological relevance and analysis of c-myc gene expression in normal human ovary. Leung C.P.K., Hsueh A.J.W., Friesen H.G. "Molecular Basis of Reproductive Endocrinology" 1993;243-249 Springer-Verlag, New York
196. Tashiro H., Katabuchi H., Begum M., Li X., Nitta M., Ohtake H., Okamura H. Roles of luteinizing hormonechorionic gonadotropin receptor in anchorage-dependent and- independent growth in human ovarian surface epithelial cell lines. Cancer Sci. 94:2003;953-959
197. Teneriello M.G., Ebina M., Linnoila R.I., Henry M., Nash J.D., Park R.C., Bierrer M.J. P53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53:1993;3103-3108
198. Tiniakos D.G., Yu H., Liapis H. Osteopontin expression in ovarian carcinomas and tumors of low malignant potential (LMP). Hum. Pathol. 29:1998;1250-1254
199. Tsao S.-W., Mok S.C., Fey E.G., Fletcher J.A., Wan T.S.K., Chew E.-C., Muto M.G., Knapp R.C., Berkowitz R.S. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp. Cell Res. 218:1995;499-507
200. Uhl-Steidl M., Muller-Holzner E., Zeimet A.G., Adolf G.R., Daxenbichler G., Marth C., Dapunt O. Prognostic value of CD44 splice variant expression in ovarian cancer. Oncology. 52:1995;400-406
201. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212
202. Underwood L.J., Tanimoto H., Wang Y., Shigemasa K., Parmley T.H., O'Brien T.J. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res. 59:1999;4435-4439
203. Veatch A.L., Carson L.F., Ramakrishnan S. Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int. J. Cancer. 58:1994;393-399
204. Vercellini P., Parazzini F., Bolis G., Carinelli S., Dindelli M., Vendola N., Luchini L., Crosignani P.G. Endometriosis and ovarian cancer. Am. J. Obstet. Gynecol. 169:1993;181-182
205. Wang Z.R., Liu W., Smith S.T., Parrish R.S., Young S.R. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Exp. Mol. Pathol. 66:1999;140-148
206. Watson J.M., Sensintaffar J.L., Berek J.S., Martinez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 50:1990;6959-6965
207. Wehrli B.M., Krajewski S., Gascoyne R.D., Reed J.C., Gilks C.B. Immunohistochemical analysis of bcl-2, bax, Mcl-1, and bcl-X expression in ovarian surface epithelial tumors. Int. J. Gynecol. Pathol. 17:1998;255-260
208. Welt C.K., Lambert-Messerlian G., Zheng W., Crowley W.F. Jr., Schneyer A.L. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J. Clin. Endocrinol. Metab. 82:1997;3720-3727
209. Werness B.A., Afify A.M., Bielat K.L., Eltabbakh G.H., Piver M.S., Paterson J.M. P53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer. Int. J. Gynecol. Pathol. 18:1999;338-343
210. White R.B., Eisen J.A., Kasten T.L., Fernald R.D. Second gene for gonadotropin-releasing hormone in humans. Proc. Natl. Acad. Sci. USA. 95:1998;305-309
211. Whittemore A.S., Harris R., Itnyre J. the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am. J. Epidemiol. 136:1992;1184-1203
212. Whittemore A.S., Gong G., Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer. Am. J. Hum. Genet. 60:1997;496-504
213. Wimalasena J., Dostal R., Meehan D. Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol. Oncol. 46:1992;345-350
214. Wong A.S.T., Pelech S.L., Woo M.M.M., Yim G., Rosen B., Ehlen T., Leung P.C.K., Auersperg N. Coexpression of hepatocyte growth factor-Met: An early step in ovarian carcinogenesis? Oncogene. 20:2001;1318-1328
215. Wu R., Lin L., Beer D.G., Ellenson L.H., Lamb B.J., Rouillard J.-M., Kuick R., Hanash S., Schwartz D.R., Fearon E.R., Cho K.R. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. Am. J. Pathol. 162:2003;1603-1610
216. Wu S., Boyer C.M., Whitaker R.S., Berchuck A., Wiener J.R., Weinberg J.B., Bast R.C. Jr. Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: Monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res. 53:1993;1939-1944
217. Yang W.-L., Godwin A.K., Xu X.-X. Tumor necrosis factor-α-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: Molecular basis linking ovulation and cancer risk. Cancer Res. 64:2004;1534-1540
218. Yang-Feng T.L., Han H., Chen K.-C., Li S., Claus E.B., Carcangiu M.L., Chambers S.K., Chambers J.T., Schwartz P.E. Allelic loss in ovarian cancer. Int. J. Cancer. 54:1993;546-551
219. Yokoyama Y., Takahashi Y., Shinohara A., Lian Z., Tamaya T. Telomerase activity in the female reproductive tract and neoplasms. Gynecol. Oncol. 68:1998;145-149
220. Zheng W., Magid M.S., Kramer E.E., Chen Y.-T. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am. J. Pathol. 148:1996;47-53
221. Zheng W., Luo M.P., Welt C., Lambert-Messerlian G., Sung C.J., Zhang Z., Ying S., Schneyer A.L., Lauchlan S.C., Felix J.C. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol. Oncol. 69:1998;23-31
222. Zheng W., Lu J.J., Luo F., Zheng Y., Feng Y., Felix J.C., Lauchlan S.C., Pike M.C. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol. Oncol. 76:2000;80-88
223. Ziltener H.J., Maines-Bandiera S., Schrader J.W., Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol. Reprod. 49:1993;635-641